← SynDRA
TALABOSTAT
SynDRA canonical compound SYN0002929 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
DPP4 | DPP7 | DPP8 | DPP9 | FAP
Mechanism of action
dipeptidyl peptidase inhibitor | fibroblast activation protein inhibitor
All known targets
DPP8
DPP9
FAP
DPP4
DPP7
Mechanisms of action (all sources)
dipeptidyl peptidase inhibitor
fibroblast activation protein inhibitor
FAP INHIBITOR
DPP8 INHIBITOR
DPP9 INHIBITOR
Cross-references
PubChem CID:
6918572
ChEMBL:
CHEMBL67279
DrugBank:
DB06182
KEGG:
D05989
TTD: D0FQ2U
Synonyms
Valinyl-l-boroproline
PT-100
Talabostat mesylate
Boroproline compounds, DARA BioSciences
Boroproline compounds, Point Therapeutics
Val-boro-Pro
Val-boroPro
PT 100
valinyl-boroproline
PT100 cpd
KZ1O2SH88Z
talabostatum
RefChem:932519
BXCL701
BXCL-701
DTXCID801511379
Val-boro-pro
L-valinyl-L-boroproline
((R)-1-(L-Valyl)pyrrolidin-2-yl)boronic acid
Pyrrolidine derivative
PT100
Val-boroPro;PT100
Talabostat [USAN]
Valinyl-L-Boroproline
Talabostat [USAN:INN]
UNII-KZ1O2SH88Z
ValboroPro
Talabostat [WHO-DD]
Ketopyrrolidine derivative
TALABOSTAT [INN]
Talabostat (USAN/INN)
SCHEMBL393024
GTPL9892
orb1692521
GLXC-15210
EX-A3155
BDBM50050513
NSC762155
NSC840949
Look up TALABOSTAT in the interactive SynDRA portal →